Influenza virus split vaccine

PMC's influenza vaccine is a split-type vaccine. Its Chinese trade name is Fangganling. Fangganling is a trivalent split-type vaccine. The three virus strains it contains (usually two strains of type A and one strain of type B) are selected annually based on the strains recommended by the World Health Organization. Fangganling was first approved for use in France in 1968. After a process of continuous improvement and perfection, it has been registered and widely used in more than 50 countries. All research data during its use of 150 million doses have shown that the protection rate of Fangganling is significantly higher than the European pharmacopoeia standard. It is effective in reducing the incidence of influenza. At the same time, due to the highly purified technology in the manufacturing process of Fangganling, the incidence of vaccination reactions is extremely low. Immunity is generated 10 to 15 days after vaccination with Fangganling and lasts for more than 1 year. Split-type

This vaccine can produce immunity against influenza virus infection 2-3 weeks after being vaccinated to prevent influenza.

Intramuscular or subcutaneous injection, children aged 6 to 35 months: 2 injections 4 weeks apart, one dose (0.25 ml) each time, shake well before use

The following persons should not use this vaccine: 1. Those suffering from acute fever, acute exacerbation of chronic diseases, and colds; 2. Those who are allergic to eggs or have other allergic history.

1. Influenza split vaccine can be administered at the same time as other vaccines, but care should be taken to select different sites for administration. 2. The use of immunosuppressants can reduce or offset the immune response after vaccination. Those who have received immunoglobulin injections should wait for more than 1 month before receiving this vaccine.

Store in a dark place at 2-8 degrees, avoid freezing

Each bottle (tube) contains 0.5ml. Each human dose is 0.5ml (for adults and children over 3 years old), and the hemagglutinin content of each influenza virus strain should be 15μg.

Lanzhou Institute of Biological Products Co., Ltd.

• Founded in:

  1983-04-04

• Address:

  No. 888, Yanchang Road, Chengguan District, Lanzhou City, Gansu Province

• Tax NO.:

  916200002243483486

• Registered Funds:

  1,816.94 million yuan

• Website:

  Log in to view

• Email:

  Log in to view